About BioPipeline

Last updated: April 27, 2026

Our Mission

BioPipeline makes molecular docking and phytochemical analysis accessible to researchers worldwide, accelerating the discovery of plant-derived therapeutics through automated computational workflows.

Traditional drug discovery from plant compounds requires expensive infrastructure, specialized expertise, and months of computational work. BioPipeline eliminates these barriers by providing a complete platform that takes a single plant name and returns publication-ready molecular docking results, ADMET profiles, and AI-powered pharmacology insights in minutes.

Scientific Approach

Our platform is built on established computational chemistry methods and validated databases:

Compound Database

BioPipeline indexes 104,000+ phytochemicals from 2,377+ plant species, sourced from Dr. Duke's Phytochemical and Ethnobotanical Databases. Each compound includes concentration data, chemical structures, and known biological activities.

Molecular Docking

We use AutoDock Vina 1.2.7, a widely-cited molecular docking tool with over 15,000 citations. Our docking protocol uses exhaustiveness=8 and generates 10 poses per compound-target pair, with binding affinities reported in kcal/mol.

Target Identification

Compounds are mapped to human protein targets using data from:

• PubChem BioAssay — bioactivity data for millions of compounds
• UniProt — protein annotations and functional data
• RCSB Protein Data Bank — 3D protein structures for docking

ADMET Predictions

Drug-likeness assessment uses RDKit descriptors and established rules:

• Lipinski's Rule of Five — oral bioavailability criteria
• CYP450 Interaction — metabolic enzyme screening (CYP2D6, CYP3A4)
• Physicochemical Properties — molecular weight, logP, hydrogen bonding

Confidence Scoring

Results are ranked using a weighted confidence score (0-100):

• Binding Affinity: 50% (stronger binding = higher score)
• Rule of Five Compliance: 30% (drug-likeness)
• ADMET Profile: 20% (safety and metabolism)

Technology Stack

BioPipeline is built with modern, scalable infrastructure:

Frontend

• Next.js 16 — React framework with server-side rendering
• React 18 — UI component library with concurrent features
• Supabase — Authentication and database
• Vercel — Global CDN and edge deployment

Backend

• FastAPI — High-performance Python API framework
• AutoDock Vina 1.2.7 — Molecular docking engine
• RDKit — Cheminformatics toolkit for ADMET analysis
• PyMOL — 3D visualization and pose rendering
• Meeko — PDBQT file preparation
• Railway — Container-based compute infrastructure

AI Integration

Pharmacology insights are generated using Groq's Llama 3 language model, which analyzes docking results, ADMET profiles, and compound properties to suggest lead candidates and experimental validation strategies.

Use Cases

BioPipeline is used by researchers across multiple domains:

Academic Research

• Drug repurposing from traditional medicine
• Natural product lead discovery
• Phytochemical mechanism-of-action studies
• Teaching computational pharmacology

Pharmaceutical Development

• Early-stage virtual screening
• Plant-derived compound optimization
• Target validation
• ADMET profiling for lead prioritization

Biotechnology

• Natural product extraction prioritization
• Bioactivity prediction
• Synthetic biology target selection

Validation & Limitations

Important: BioPipeline provides computational predictions, not experimental results. All findings should be validated in vitro and in vivo before drawing biological conclusions.

What BioPipeline Does Well

• Rapid screening of thousands of compound-target pairs
• Identification of potential binding interactions
• Prioritization of compounds for experimental testing
• Drug-likeness assessment using established rules

Known Limitations

• Binding affinity predictions are estimates (±2 kcal/mol typical accuracy)
• ADMET predictions require experimental validation
• Protein structures may not reflect physiological conformations
• Does not account for metabolic activation or multi-target effects

Data Quality

We prioritize data accuracy and provenance:

• All plant compound data sourced from peer-reviewed databases
• Protein structures verified through RCSB PDB quality metrics
• Regular updates to compound library and target annotations
• Transparent reporting of confidence scores and data sources

For Academic Use

Academic institutions receive 50% discount on Pro and Max plans. Contact us with your .edu email address: billing@biopipeline.online

Citations

If you use BioPipeline in your research, please cite:

BioPipeline: Automated Plant-to-Target Molecular Docking Platform.
https://www.biopipeline.online (2025-2026)

Contact

Open Science

We believe in transparency and reproducibility. All methodologies are documented in our public documentation, and we provide detailed provenance for all data sources.

Interested in contributing or collaborating? Reach out at research@biopipeline.online